The Therapeutic Goods Administration issued a new warning for GLP-1 receptor agonists, including Ozempic and Mounjaro, on ...

FDA and WHO identified semaglutide suicidal thought reports, exceeding those of other diabetes medications in their adverse ...

The most common side effects of GLP-1 medicines are related to digestion: nausea, vomiting, diarrhoea, indigestion, stomach ...

New precautions added for GLP-1 drugs as reports of mood changes and contraceptive concerns emerge in Australia.

While the WHO study saw reports of suicidal thoughts were slightly higher for semaglutide in particular, the warning applies ...

Novo Nordisk, Eli Lilly call their diabetes and weight loss drugs “safe and effective” as they face accusations in lawsuits ...

The rise of GLP-1 drugs such as Ozempic and Mounjaro has been nothing short of meteoric. Originally developed to treat ...

Australia’s top drug regulator has issued a fresh safety warning about the potential risk of suicidal thoughts and ...

Patients on popular GLP-1 weight-loss and diabetes jabs should be monitored for suicidal behaviour, the TGA says, while ...

The Australian medicines regulator has issued a mental health safety warning for a drug widely used for weight loss.

The Therapeutic Goods Administration (TGA) has warned patients taking GLP-1 weight loss and diabetes jabs should be monitored for suicidal behaviour.